Topics:
acute promyelocytic leukemia, education, medical, continuing, idarubicin, tretinoin
This content is only available as a PDF.
© 2010 by The American Society of Hematology
2010

Article PDF first page preview

First page of Continuing Medical Education (CME) questions: Treatment of acute promyelocytic leukemia based on 2 regimens (LPA99- ATRA + idarubicin -AIDA and LPA2005-risk adjusted)
Sign in via your Institution